Search

everythinglearnresearchcommunity

for

Search:↓

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Both mouse and rat models are effective for testing alopecia areata treatments.

People with PCNT mutations often develop severe insulin resistance and early-onset diabetes during childhood or adolescence.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Macrophages are essential for successful skin growth in reconstructive surgery.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Hydrogen peroxide and monoethanolamine in hair dye can cause dermatitis and hair loss.

ROOT HAIR SPECIFIC 10 (RHS10) reduces the length of root hairs in Arabidopsis plants.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Red deer only have androgen receptors in neck hair cells for mane growth during breeding season.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

Non-immune factors play a significant role in alopecia areata.

Hair follicle stem cells are promising for wound healing but require more research for safe clinical use.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.